{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T15:11:43Z","timestamp":1771081903567,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T00:00:00Z","timestamp":1480032000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s40801-016-0100-7","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T01:47:14Z","timestamp":1480038434000},"page":"53-63","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Examining the Quality of Medicines at Kenyan Healthcare Facilities: A Validation of an Alternative Post-Market Surveillance Model That Uses Standardized Patients"],"prefix":"10.1007","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5761-6151","authenticated-orcid":false,"given":"Francis","family":"Wafula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Dolinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Njeri","family":"Mwaura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guadalupe","family":"Bedoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khama","family":"Rogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Goicoechea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jishnu","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Olayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,25]]},"reference":[{"key":"100_CR1","unstructured":"WHO. The Safety of Medicines in Public Health Programmes: Pharmacovigilance, an essential tool. Geneva: World Health Organization; 2006."},{"key":"100_CR2","unstructured":"WHO. A Report of the Safety and Surveillance Working Group (Supported by the Bill and Melinda Gates Foundation). 2013. World Health Organization Safety and Surveillance Working Group http:\/\/apps.who.int\/medicinedocs\/en\/d\/Js21347en\/ ."},{"key":"100_CR3","doi-asserted-by":"crossref","unstructured":"Wafula F, et al. The policy-practice gap: describing discordances between regulation on paper and real-life practices among specialized drug shops in Kenya. BMC Health Serv Res, 2014;14(394).","DOI":"10.1186\/1472-6963-14-394"},{"key":"100_CR4","unstructured":"WHO. Survey of the Quality of Antimalarials in Sub-Saharan Africa (QAMSA). Geneva: World Health Organization; 2010."},{"issue":"6 Suppl","key":"100_CR5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4269\/ajtmh.15-0221","volume":"92","author":"GM Nayyar","year":"2015","unstructured":"Nayyar GM, Breman JG, Herrington JE. The global pandemic of falsified medicines: laboratory and field innovations and policy perspectives. Am J Trop Med Hyg. 2015;92(6 Suppl):2\u20137.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"100_CR6","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1371\/journal.pmed.1000052","volume":"6","author":"PN Newton","year":"2009","unstructured":"Newton PN, et al. Guidelines for field surveys of the quality of medicines: a proposal. PLoS Med. 2009;6(3):e52.","journal-title":"PLoS Med"},{"key":"100_CR7","doi-asserted-by":"crossref","first-page":"h602","DOI":"10.1136\/bmj.h602","volume":"350","author":"PN Newton","year":"2015","unstructured":"Newton PN, et al. Quality assurance of drugs used in clinical trials: proposal for adapting guidelines. BMJ. 2015;350:h602.","journal-title":"BMJ"},{"issue":"9","key":"100_CR8","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.1016\/S2214-109X(14)70279-7","volume":"2","author":"PN Newton","year":"2014","unstructured":"Newton PN, et al. Falsified medicines in Africa: all talk, no action. Lancet Glob Health. 2014;2(9):e509\u201310.","journal-title":"Lancet Glob Health"},{"key":"100_CR9","doi-asserted-by":"crossref","unstructured":"Bate R, et al. Poor quality drugs and global trade: a pilot study. Cambridge: National Bureau of Economic Research; 2014. NBER Working Paper Series. Working Paper 20469.","DOI":"10.3386\/w20469"},{"issue":"6 Suppl","key":"100_CR10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4269\/ajtmh.14-0725","volume":"92","author":"JP Renschler","year":"2015","unstructured":"Renschler JP, et al. Estimated under-five deaths associated with poor-quality antimalarials in sub-Saharan Africa. Am J Trop Med Hyg. 2015;92(6 Suppl):119\u201326.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"100_CR11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1475-2875-4-36","volume":"4","author":"AA Amin","year":"2005","unstructured":"Amin AA, Snow RW. Brands, costs and registration status of antimalarial drugs in the Kenyan retail sector. Malar J. 2005;4(1):36.","journal-title":"Malar J"},{"key":"100_CR12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1471-2458-8-157","volume":"8","author":"MW Hetzel","year":"2008","unstructured":"Hetzel MW, et al. Malaria treatment in the retail sector: knowledge and practices of drug sellers in rural Tanzania. BMC Public Health. 2008;8:157.","journal-title":"BMC Public Health"},{"issue":"3","key":"100_CR13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.pec.2010.09.001","volume":"81","author":"W Liambila","year":"2010","unstructured":"Liambila W, Obare F, Keesbury J. Can private pharmacy providers offer comprehensive reproductive health services to users of emergency contraceptives? Evidence from Nairobi, Kenya. Patient Educ Couns. 2010;81(3):368\u201373.","journal-title":"Patient Educ Couns"},{"key":"100_CR14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1475-2875-2-10","volume":"2","author":"P Tavrow","year":"2003","unstructured":"Tavrow P, Shabahang J, Makama S. Vendor-to-vendor education to improve malaria treatment by private drug outlets in Bungoma District, Kenya. Malar J. 2003;2:10.","journal-title":"Malar J"},{"key":"100_CR15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/1472-6963-12-223","volume":"12","author":"FN Wafula","year":"2012","unstructured":"Wafula FN, Miriti EM, Goodman CA. Examining characteristics, knowledge and regulatory practices of specialized drug shops in Sub-Saharan Africa: a systematic review of the literature. BMC Health Serv Res. 2012;12:223.","journal-title":"BMC Health Serv Res"},{"key":"100_CR16","unstructured":"Daniels et al. Standardized patients in Kenyan health care facilities: validation and pilot results [draft under preparation]."},{"key":"100_CR17","volume-title":"Constitution of Kenya, 2010","author":"Government of Kenya","year":"2010","unstructured":"Government of Kenya. Constitution of Kenya, 2010. Nairobi: Government of Kenya; 2010."},{"issue":"6","key":"100_CR18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/heapol\/czm033","volume":"22","author":"C Goodman","year":"2007","unstructured":"Goodman C, et al. Drug shop regulation and malaria treatment in Tanzania: why do shops break the rules, and does it matter? Health Policy Plan. 2007;22(6):393\u2013403.","journal-title":"Health Policy Plan"},{"key":"100_CR19","unstructured":"DOMC & PPB. Monitoring the Quality of Antimalarial Medicines Circulating in Kenya. Nairobi: Division of Malaria Control [Ministry of Public Health and Sanitation], Pharmacy and Poisons Board; 2011."},{"key":"100_CR20","unstructured":"DOMC & PPB. Monitoring the Quality of Antimalarial Medicines Circulating in Kenya. Nairobi: Division of Malaria Control [Ministry of Public Health and Sanitation], Pharmacy and Poisons Board; 2012."},{"key":"100_CR21","unstructured":"DOMC & PPB. Monitoring the Quality of Antimalarial Medicines Circulating in Kenya. Nairobi: Division of Malaria Control [Ministry of Public Health and Sanitation], Pharmacy and Poisons Board; 2013."},{"issue":"5","key":"100_CR22","doi-asserted-by":"crossref","first-page":"e2132","DOI":"10.1371\/journal.pone.0002132","volume":"3","author":"R Bate","year":"2008","unstructured":"Bate R, et al. Antimalarial drug quality in the most severely malarious parts of Africa - a six country study. PLoS One. 2008;3(5):e2132.","journal-title":"PLoS One"},{"issue":"6 Suppl","key":"100_CR23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4269\/ajtmh.14-0394","volume":"92","author":"M Lalani","year":"2015","unstructured":"Lalani M, et al. Substandard antimalarials available in Afghanistan: a case for assessing the quality of drugs in resource poor settings. Am J Trop Med Hyg. 2015;92(6 Suppl):51\u20138.","journal-title":"Am J Trop Med Hyg"},{"issue":"6 Suppl","key":"100_CR24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4269\/ajtmh.14-0391","volume":"92","author":"S Yeung","year":"2015","unstructured":"Yeung S, et al. Quality of antimalarials at the epicenter of antimalarial drug resistance: results from an overt and mystery client survey in Cambodia. Am J Trop Med Hyg. 2015;92(6 Suppl):39\u201350.","journal-title":"Am J Trop Med Hyg"},{"key":"100_CR25","doi-asserted-by":"publisher","first-page":"e002923","DOI":"10.1136\/bmjopen-2013-002923","volume":"3","author":"T Almuzaini","year":"2013","unstructured":"Almuzaini T, Choonara I, Sammons H. Substandard and counterfeit medicines: a systematic review of the literature. BMJ Open. 2013;3:e002923. doi: 10.1136\/bmjopen-2013-002923","journal-title":"BMJ Open"},{"key":"100_CR26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/RRTM.S33108","volume":"3","author":"R Bate","year":"2012","unstructured":"Bate R, et al. Anti-infective medicine quality: analysis of basic product quality by approval status and country of manufacture. Res Rep Trop Med. 2012;3:57\u201361.","journal-title":"Res Rep Trop Med"}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-016-0100-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40801-016-0100-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-016-0100-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T19:36:20Z","timestamp":1568576180000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40801-016-0100-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,25]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["100"],"URL":"https:\/\/doi.org\/10.1007\/s40801-016-0100-7","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"value":"2199-1154","type":"print"},{"value":"2198-9788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,25]]}}}